Dow Down0.17% Nasdaq Down0.28%

Heron Therapeutics, Inc. (HRTX)

-NasdaqCM
8.33 0.44(5.02%) Sep 30, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development14,427  11,771  9,592  5,242  
Selling General and Administrative4,364  5,551  4,239  7,422  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (18,791) (17,322) (13,831) (12,664)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes(18,791)(17,322)(13,831)(12,664)
Interest Expense220  216  212  209  
Income Before Tax(19,011)(17,538)(14,043)(12,873)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(19,011)(17,538)(14,043)(12,873)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (19,011) (17,538) (14,043) (12,873)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (19,011) (17,538) (14,043) (12,873)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.